ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
3
views
0
references
Top references
cited by
8
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,620
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Smoking History as a Predictive Factor of Treatment Response in Advanced Non–Small-Cell Lung Cancer: A Systematic Review
Author(s):
Paul Mitchell
,
Tony Mok
,
Helen Barraclough
,
Alena Strizek
,
Rebecca Lew
,
Maximiliano Van Kooten
Publication date:
2012-07-01
Journal:
Clinical Lung Cancer
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
New directions in predictive processing
Author and article information
Journal
DOI::
10.1016/j.cllc.2011.08.003
PubMed ID::
22154074
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,620
Most T790M mutations are present on the same EGFR allele as activating mutations in patients with non-small cell lung cancer.
Authors:
Noriko Hidaka
,
Eiji Iwama
,
Naoki Kubo
…
Impacts of early smoking initiation: long-term trends of lung cancer mortality and smoking initiation from repeated cross-sectional surveys in Great Britain
Authors:
Ikuko Funatogawa
,
Takashi Funatogawa
,
Eiji Yano
IMpower110: Clinical safety in a phase III study of atezolizumab (atezo) monotherapy (mono) vs platinum-based chemotherapy (chemo) in first-line non-small cell lung cancer (NSCLC).
Authors:
J Jassem
,
RS Herbst
,
F De Marinis
…
See all similar
Cited by
8
Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Authors:
Amit Jain
,
Cindy Lim
,
Eugene MingJin Gan
…
Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study
Authors:
In Ae Kim
,
Jong Sik Lee
,
Hee Kim
…
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer
Authors:
Allen Huang
,
Chi-Hsien Huang
,
Jia-Shiuan Ju
…
See all cited by
Version 1
- Current
Version 1